Saccharomyces cerevisiae-secreted fusion proteins Pfs25 and Pfs28 elicit potent Plasmodium falciparum transmission-blocking antibodies in mice.
about
Algae-produced Pfs25 elicits antibodies that inhibit malaria transmissionThe cell biology of malaria infection of mosquito: advances and opportunitiesStrategies & recent development of transmission-blocking vaccines against Plasmodium falciparumThe March Toward Malaria VaccinesThe chitinase PfCHT1 from the human malaria parasite Plasmodium falciparum lacks proenzyme and chitin-binding domains and displays unique substrate preferencesA region of Plasmodium falciparum antigen Pfs25 that is the target of highly potent transmission-blocking antibodiesMicronemal transport of Plasmodium ookinete chitinases to the electron-dense area of the apical complex for extracellular secretionAntibodies to malaria vaccine candidates Pvs25 and Pvs28 completely block the ability of Plasmodium vivax to infect mosquitoes.Efficacy of two alternate vaccines based on Plasmodium falciparum merozoite surface protein 1 in an Aotus challenge trial.Disruption of Plasmodium falciparum chitinase markedly impairs parasite invasion of mosquito midgut.Blocking effect of a monoclonal antibody against recombinant Pvs25 on sporozoite development in Anopheles sinensis.Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparumIdentification of novel Plasmodium gallinaceum zygote- and ookinete-expressed proteins as targets for blocking malaria transmission.Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and eliminationP25 and P28 proteins of the malaria ookinete surface have multiple and partially redundant functionsLimited polymorphism in Plasmodium falciparum ookinete surface antigen, von Willebrand factor A domain-related protein from clinical isolates.Antigenic repertoire of Plasmodium vivax transmission-blocking vaccine candidates from the Indian subcontinent.Alga-produced malaria transmission-blocking vaccine candidate Pfs25 formulated with a human use-compatible potent adjuvant induces high-affinity antibodies that block Plasmodium falciparum infection of mosquitoes.Comparative assessment of transmission-blocking vaccine candidates against Plasmodium falciparum.Effect of CpG oligodeoxynucleotides on the immunogenicity of Pfs25, a Plasmodium falciparum transmission-blocking vaccine antigen.Functional evaluation of malaria Pfs25 DNA vaccine by in vivo electroporation in olive baboonsAlga-produced cholera toxin-Pfs25 fusion proteins as oral vaccines.Malaria ookinete surface protein-based vaccination via the intranasal route completely blocks parasite transmission in both passive and active vaccination regimens in a rodent model of malaria infection.Potent malaria transmission-blocking antibody responses elicited by Plasmodium falciparum Pfs25 expressed in Escherichia coli after successful protein refolding.The march toward malaria vaccines.Assessment of Antibodies Induced by Multivalent Transmission-Blocking Malaria Vaccines.Plasmodium translationally repressed gene products are essential for parasite development and malaria transmission.
P2860
Q21134576-58F642C5-4440-43B3-8728-219C856E6F70Q27024179-D119D72A-026F-4A83-90B0-8AAD630DE4A2Q28072195-F5424EB3-57C6-455B-84CB-B76A802E486AQ28084325-C305E8CC-489C-48B6-93BF-62C60223747BQ30041470-37BAC3EF-F645-4EDC-B2CC-946DDBB8470AQ33591209-ABFE31DE-CBF2-4D96-8272-06CB1E991F6CQ34005064-9D15301B-F31D-4B22-AFF5-838F894F682FQ34005142-4179DB03-0B64-4132-91B3-6E9482245819Q34006332-39939A1B-4AFE-4D87-92AD-FFAE77C1A694Q34008076-7EFCD26D-B864-42E7-B5C7-C4D1CF852D92Q34045009-4C320249-8CC5-4E40-B09F-B1857FB0B327Q34111897-99E6BB36-3B60-4982-8FC4-87F6F2B04A8FQ34116333-746C99C8-4E39-4A34-8810-322235563F6BQ34177472-F3562E16-DCBA-4CEA-BAE8-F708A424FA5BQ34729130-02534CFB-08CF-4885-AD79-08CACACC5E7CQ34899015-6AEB9974-FEA8-42BF-B57B-CE662B2F3532Q35014586-7FC4DC49-B2CB-4826-9CB7-41E0F660D9D5Q35439931-A1F1FB20-D851-4534-9239-ED12919E9569Q35718341-674EFF1E-CC59-482F-8AAE-6F7EB521D65CQ36228960-A674BA6E-140E-419A-B00F-B308CDBC4A79Q36941152-9BFFA8FC-C777-44FA-972B-34B2A6300DBBQ36970645-C88D5636-6AFF-4A74-B89A-F4F830778BD4Q37451022-4E190A58-F465-4735-B18A-8A4E928AB6EDQ37713285-E9F25EC6-3911-430E-8B18-575BE11E6EF8Q38577638-089C3808-524D-44B1-88BF-34781DB9C11FQ49730085-01AC020C-5410-4B62-B4D8-D42BF9E8DC0EQ55082188-52BDC020-47F9-4163-B47B-B36178868AFD
P2860
Saccharomyces cerevisiae-secreted fusion proteins Pfs25 and Pfs28 elicit potent Plasmodium falciparum transmission-blocking antibodies in mice.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Saccharomyces cerevisiae-secre ...... n-blocking antibodies in mice.
@ast
Saccharomyces cerevisiae-secre ...... n-blocking antibodies in mice.
@en
type
label
Saccharomyces cerevisiae-secre ...... n-blocking antibodies in mice.
@ast
Saccharomyces cerevisiae-secre ...... n-blocking antibodies in mice.
@en
prefLabel
Saccharomyces cerevisiae-secre ...... n-blocking antibodies in mice.
@ast
Saccharomyces cerevisiae-secre ...... n-blocking antibodies in mice.
@en
P2093
P2860
P1476
Saccharomyces cerevisiae-secre ...... on-blocking antibodies in mice
@en
P2093
P2860
P407
P577
1998-01-01T00:00:00Z